Two Sigma Securities’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Two Sigma Securities’s Portfolio RSLS Stock Details RSLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-260	Closed	-$2K	–	3121
2018 Q3	$2K	Buy	+260	New	+$22.4K	﹤0.01%	2522

Other funds holding RSLS

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Two Sigma Securities's RSLS Position: Q4 2018 in Review

Two Sigma Securities sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 260 shares — an estimated $2K sold.

Two Sigma Securities first reported a position in RSLS in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

Two Sigma Securities reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Two Sigma Securities sold 260 ReShape Lifesciences Inc. Common Stock shares in Q4 2018, an estimated $2K.
Two Sigma Securities first reported a position in ReShape Lifesciences Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Two Sigma Securities's ReShape Lifesciences Inc. Common Stock position peaked at $2K in Q3 2018.
2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on Two Sigma Securities's 13F filing for Q4 2018, filed 14 Feb 2019.